WGC2025 Hula Girl
11th WORLD GLAUCOMA CONGRESS
JUNE 25 - 28, 2025 - HONOLULU, HAWAII, USA

WGC-2025 WILL START IN

Days
Hours
Mins
Secs
Facebook-f X-twitter Linkedin-in Instagram
Facebook-f X-twitter Linkedin-in Instagram

Industry Sessions

All Thursday, June 26 Friday, June 27
Topcon

Thursday, June 26

(7:00am – 8:00am HST)

Room 315

Visual Field Solutions to Optimize Glaucoma Workflow
Innovation and connectivity with Inspire; Improving clinic flow with binocular perimetry

Moderator

Robert Weinreb, MD

Presenters

  • Ike Ahmed, MD, FRCSC

Innovation and connectivity – use of novel medical testing glasses with connectivity to reduce clinical bottlenecks

  • Sasan Moghimi, MD

Improving clinic flow with an innovative binocular perimetry algorithm that enables speed without compromise in glaucoma detection and management

By clicking here to discover the session’s program I confirm I am a healthcare professional
iCare – Industry Showcase

Thursday, June 26

(2:30pm – 3:00pm HST)

Exhibition hall

Evolving standards in glaucoma care: Enhancing diagnostic precision through innovation.

Speakers

  • Prof. Luca Rossetti

iCare ST500 – a new era in slit lamp tonometry

  • Prof. Christopher K.S. Leung

Beyond Standard Automated Perimetry – Applications of iCare COMPASS in glaucoma care

Santen

Thursday, June 26

(5:30pm – 6:30pm HST)

Room 315

Deconstructing glaucoma: A clearer picture of the science driving medical therapy

Faculty

Chair: Prof. Tetsuya Yamamoto (Japan)
Speakers: Prof. Youn Hye Jo (Korea); Prof. Anthony Khawaja (UK); Dr. Junyi Chen (China)

Agenda

Time (HST)SessionSpeaker(s)
5:30-5:35Welcome and introductionProf. Tetsuya Yamamoto
5:35-5:50Snapshots in time: The evolution of glaucoma therapyProf. Youn Hye Jo
5:50-6:05Zooming in: The structures underlying IOP controlProf. Anthony Khawaja
6:05-6:20The patient’s angle: Optimizing therapy for real-world effectivenessProf. Junyi Che
6:20-6:30Panel discussion with Q&A Summary and closeAll; moderated by Prof. Tetsuya Yamamoto
Inami

Thursday, June 26

(5:30pm – 6:30pm HST)

Room 312

Uniting Continents in Glaucoma Care TMH’s Global Impact with Support from XpandNT

Chair

Dr. Masaki Tanito (Shimane University), Japan

Speakers
  • Dr. Henry-S.-L-Chen (Chang Gung Memorial Hospital), Taiwan

Micro-invasive Glaucoma Angle Surgery Goniotomy for Implant Free

  • Dr. Sasan Moghimi (Shiley Eye Institute), USA

MIGS is not expensive Experience with Micro Hook Shoji Edition Tailored for American Patients

  • Dr. Tomoyuki Chihara (Chihara Eye Clinic), Japan

T-hook: Advancing Trabeculotomy with Superior Safety, Precision, and Surgical Control. Complemented by XpandNT: Providing Consistent and Secure Pupil Expansion for Small Pupils and Pseudoexfoliation Syndrome

AOI

Thursday, June 26

(5:30pm – 6:30pm HST)

Room 313A

Ride the Wave – Mastering Success with the PAUL® Implant

Topic 1

Ride the Best-practice Wave: Implanting PAUL®

(Design applications and surgical technique)

Presenters: Victor Koh (SG) & Keith Barton (UK)

Topic 2

Beyond the Wave: Hear from the Experts

(clinical applications & QnA)

Moderator: Joseph Panarelli (USA)

Expert Panel: Paul Chew (SG), Keith Barton (UK), Graham Lee (AUS) & Victor Koh (SG)

Glaukos

Friday, June 27

(7:00am – 8:00am HST)

Room 312

Empowering Interventional Glaucoma Care
The Innovative Role of iStent infinite and iDose TR in the Modern Practice

Presenters

  • Ike Ahmed
  • Mitchell Lawlor (Australia)
  • Manjool Shah
  • what’s driving the movement to become more interventional?
  • practice assessment data snapshot
  • the need for broad alignment around the emerging standard of care
  • the unmet need for standalone procedures
  • the consensus protocol
  • how do innovative technologies fit into the IG treatment protocol
  • IFU (by region – explain differences)
  • product overview
  • pivotal data
  • competitive data (FGB data, integrity announcement and QR code only)
  • standalone surgical video/case plus results (US patient/case with failed surg)
  • call to action – what should the audience do next
  • IFU
  • product overview
  • pivotal data
  • procedural video/case plus results
  • call to action – what should the US audience do next
  • time to think and act differently
  • Take back control – acknowledge compliance and adherence reality
  • don’t react to glaucoma, treat it proactively
  • utilize proven safe and effective technologies
Optopol

Friday, June 27

(7:00am – 8:00am HST)

Room 313A

Visual Function, Posterior and Anterior Imaging in Glaucoma Management

  • Dr. María Fernanda Rebollo Ramírez

Improving Patient and Clinician Experience in Visual Field Testing

CONTENT: Brief presentation of the results of a clinical study focused on selectivity and sensitivity. Improvements in patient and clinician experience in perimetry examination with the PTS 2000 perimeter.

  • Prof. Adam Wylęgała 

Anterior Segment Imaging in Glaucoma Management

CONTENT: Anterior chamber imaging, angle imaging and measurement, pachymetry/IOP correction.

  • Dr. Jesús Jiménez Román

Building Confidence in Early Glaucoma Detection – Structure and Function Analysis

CONTENT: Ganglion cells analysis examples, NFL and ONH analysis and clinical examples. Completeness of diagnosis embracing symmetry comparison, progression analysis, the ADVANCED tab view, and the REVO S&F report in the COMBINED tab including VF data from the PTS perimeters.

Abbvie

Friday, June 27

(11:45am – 12:45pm HST)

Ballroom

Optimizing Outflow for Minimally Invasive Filtering Surgery

Presenters

  • Sahar Bedrood, MD
  • Ike Ahmed, MD

Lunch will be available

 

Please contact our Professional Congress Organizer MCI for all your WGC-2025 questions wgc@mci-group.com 

MCI The Netherlands
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands

World Glaucoma Association
www.worldglaucoma.org

Facebook-f X-twitter Linkedin-in Instagram
Abbvie

Thursday, June 29

(7:30 – 8:30 CEST)

Advances in Glaucoma Management

Click to discover the session’s program
7.30-7.35Welcome and IntroductionsChair: Ike Ahmed (Canada)
7.35-7.50Clinically meaningful VF progression and determine Target IOPDan Lindfield (United Kingdom)
7.50-8.05Will artificial intelligence transform Glaucoma care in future?Ingeborg Stalmans (Belgium)
8.05-8.20Changing dimensions in surgical options: Blebless MIGS vs MIBSIke Ahmed (Canada)
Abbvie

Thursday, June 29

(12:15 – 13:15 CEST)

Beyond the surface: targeted delivery and sustained control

Click to discover the session’s program
12:15-12:20WelcomeStefano Gandolfi (Italy)
12:20-12:35Limitations of drop therapyFrancesco Oddone (Italy)
12:35-12:50SLT in RCTs vs. RWEAnthony Khawaja (United Kingdom)
12:50-13:05Targeted Delivery: Role of MMPs in the outflow pathwaysIke Ahmed (Canada)
13:05-13:15Q&A and discussionStefano Gandolfi (Italy)
Abbvie

Friday, June 30

(12:15 – 13:15 CEST)

AbbVie industry sponsored luncheon symposium for Healthcare Professionals only
Interventional glaucoma: a management approach with XEN® gel implant

Click to discover the session’s program

Chairs:

  • Carlo Traverso, University of Genova, Italy
  • Stefano Gandolfi, University of Parma, Parma, Italy
  • Jose M. Martinez de la Casa. Hospital Clinico San Carlos, Madrid, Spain

Speakers:

  • Roberto Carassa, Centro Italiano Glaucoma, Milan, Italy
  • Antonio Fea, Università Degli Studi di Torino, Italy
  • Michele Figus, University of Pisa, Italy
TimeTitlePresenter
12:15–12:20Symposium agenda and objectivesCarlo Traverso (Italy)
12:20–12:33Are we ready to change our approach to glaucoma management?Roberto Carassa (Italy)
12:33–12:46A step forward in the interventional glaucoma approach with XEN®63 in patients with primary open-angle-glaucomaAntonio Fea (Italy)
12:46–12:59Maximize the micro-incisional XEN®63 surgery option at the right time: pre-operative preparation, surgery technique and post-operative careMichele Figus (Italy)
12:59–13:15Faculty discussion

Stefano Gandolfi (Italy)

Jose M. Martinez de la Casa (Spain)

Carlo Traverso (Italy)

XEN® Gel Implant is a CE Marked class III Medical Device. CE2797
XEN® Gel Implant is intended to reduce intraocular pressure in patients with primary open angle glaucoma where previous medical treatments have failed.
Materials developed in accordance with CE mark.
Registration conditions and licenses differ internationally, please refer to your local Directions for Use. A list of countries with this product/ indication is available from ukmedinfo@abbvie.com For further information please consult your country Directions For Use. 
Adverse events should be reported to your Ministry of Health and local AbbVie office.
Medical devices have associated risks, please refer to the contraindications, warnings and precautions sections in the Directions For Use.

Promotional symposium organised and funded by Abbvie.

ALL-XEN-230005 – April 2023